Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ellen K Kendall"'
Autor:
Rong Xu, David C Kaelber, Pamela B Davis, Pauline Terebuh, Veronica R Olaker, Ellen K Kendall
Publikováno v:
Family Medicine and Community Health, Vol 12, Iss 1 (2024)
Objective Beginning in October 2021 in the USA and elsewhere, cases of severe paediatric hepatitis of unknown aetiology were identified in young children. While the adenovirus and adenovirus-associated virus have emerged as leading aetiological suspe
Externí odkaz:
https://doaj.org/article/943ce06a73fb4e09a2f8fb3580aa552b
Autor:
Maria P. Gorenflo, Pamela B. Davis, Ellen K. Kendall, Veronica R. Olaker, David C. Kaelber, Rong Xu
Publikováno v:
Journal of Alzheimer's Disease. 91:697-704
Background: Currently there are no effective therapies to prevent or halt the development of Alzheimer’s disease (AD). Multiple risk factors are involved in AD, including ischemic stroke (IS). Aspirin is often prescribed following IS to prevent blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de8531f14487cebad4da3234d1e98b53
https://doi.org/10.3233/jad-220901
https://doi.org/10.3233/jad-220901
Recently, the Centers for Diseases and Control released a nationwide health alert about an increase in hepatitis cases of unknown origin in children, raising concern about potential sequelae of COVID-19 infection. In this study, we test whether there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108f604d3e84d565a85b581493f95eea
https://doi.org/10.1101/2022.05.10.22274866
https://doi.org/10.1101/2022.05.10.22274866
Autor:
Sarah E. M. Herman, Hailey Harris, Priti Patel, Raquel Izumi, Maryalice Stetler-Stevenson, Constance M. Yuan, Michael Gulrajani, Todd Covey, Irina Maric, Christopher Pleyer, Jean Cheung, Adrian Wiestner, Stefania Pittaluga, Min Hui Wang, Clare Sun, Pia Nierman, Mohammed Farooqui, Ellen K. Kendall, Erika M Gaglione, Inhye E. Ahn, Ahmed Hamdy
Publikováno v:
Blood. 136:93-105
Inhibition of the B-cell receptor pathway, and specifically of Bruton tyrosine kinase (BTK), is a leading therapeutic strategy in B-cell malignancies, including chronic lymphocytic leukemia (CLL). Target occupancy is a measure of covalent binding to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c2ccd10671085e06e6fbd8849b4c0af
https://doi.org/10.1182/blood.2019003715
https://doi.org/10.1182/blood.2019003715
Autor:
Veronica R. Olaker, Ellen K. Kendall, Christina X. Wang, Theodore V. Parran, Pauline Terebuh, David C. Kaelber, Rong Xu, Pamela B. Davis
Publikováno v:
JAMA Network Open. 6:e2255496
ImportanceThe COVID-19 pandemic affects many diseases, including alcohol use disorders (AUDs). As the pandemic evolves, understanding the association of a new diagnosis of AUD with COVID-19 over time is required to mitigate negative consequences.Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c4a735bd3e909108aec4467b9a21b1d
https://doi.org/10.1001/jamanetworkopen.2022.55496
https://doi.org/10.1001/jamanetworkopen.2022.55496
Autor:
Adrian Wiestner, Christoph Rader, Junpeng Qi, David Eik, Maissa Mhibik, Amy Blackburn, Ellen K Kendall, Erika M Gaglione, Inhye E. Ahn, Keyvan Keyvanfar, Clare Sun, Maria Joao Baptista
Publikováno v:
Blood
Bruton tyrosine kinase inhibitors (BTKis) are a preferred treatment of patients with chronic lymphocytic leukemia (CLL). Indefinite therapy with BTKis, although effective, presents clinical challenges. Combination therapy can deepen responses, shorte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d35499edf8df936d2a9410e08289b05
https://europepmc.org/articles/PMC8586964/
https://europepmc.org/articles/PMC8586964/
Publikováno v:
JAMA Network Open. 5:e2233014
This cohort study assesses the association of COVID-19 with new-onset type 1 diabetes among pediatric patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7b413a07178a369c6be490e96667a4
https://doi.org/10.1001/jamanetworkopen.2022.33014
https://doi.org/10.1001/jamanetworkopen.2022.33014
Autor:
Jianjun Zhao, Ellen K. Kendall, Laeth George, S. Deshpande, Asmi Chattaraj, Faiz Anwer, Matthew J Cortese, Zunairah Shah
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(11)
Multiple myeloma is the second most common hematologic malignancy and remains incurable. Patients who fail multiple lines of therapy typically have a poor prognosis despite recent advances in myeloma treatment. Chimeric antigen receptor T (CAR T) cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00d34092ce4fff6791fe12738728304
https://pubmed.ncbi.nlm.nih.gov/34253497
https://pubmed.ncbi.nlm.nih.gov/34253497
Autor:
Rachel Kositsky, Andrew Ip, Shakthi Bhaskar, Rakhee Vaidya, Andre Goy, Ahmed Galal, Tushar Dave, Nirav N. Shah, Charalambos Andreadis, Deborah M. Stephens, Eric D. Hsi, Kavya Kannan, Swetha Kambhampati, Boyu Hu, Kenneth Ofori, Matthew McKinney, Sandeep S. Dave, Chrissie Rozzi, Caroline J Roth, Robert Ferdman, Joanna C. Zurko, Nilanjan Ghosh, John M. Pagel, Brian T. Hill, Ellen K. Kendall, Ashley M. Cunningham, Elizabeth Thacker, Neil Bailey, Jadee L. Neff, Matthew Chiaramonte, George Chen, Alexandra E. Kovach, Robert S. Ohgami, Govind Bhagat, Ran Reshef, Olalekan O. Oluwole, Tarsheen K. Sethi, Agrima Mian, Cassandra Love, Sarah L. Ondrejka, Lanie Happ, Clay Parker, Francisco J. Hernandez-Ilizaliturri, Monalisa Ghosh, Krish Patel, Emily F. Mason, Christopher Pallas
Publikováno v:
Blood. 138:165-165
INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) represents several distinct clinical pathologic entities recently identified by molecular profiling. Treatment with anti-CD19 chimeric antigen receptor (CAR) T-cell therapies is now standard for many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::263fdfa7dcca8e6ac17f2cfe598aab81
https://doi.org/10.1182/blood-2021-145764
https://doi.org/10.1182/blood-2021-145764
Autor:
Sarah L. Ondrejka, Bo Hu, Yazeed Sawalha, Manishkumar S. Patel, Agrima Mian, Eric D. Hsi, Ellen K. Kendall, Neetu Gupta, Brian T. Hill
Publikováno v:
Blood. 136:26-26
Background Diffuse large B cell lymphoma (DLBCL) is curable in ~60-70% of patients using standard chemoimmunotherapy, but the prognosis is poor for relapsed/refractory (R/R) DLBCL. Therefore, understanding the underlying molecular mechanisms will fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dd11344f966c26a094bbb30ae3d788a
https://doi.org/10.1182/blood-2020-138645
https://doi.org/10.1182/blood-2020-138645